Management of Established Tetanus Cases

Immediate Interventions

The Centers for Disease Control and Prevention recommends administering human TIG immediately at a dose of 250-500 units intramuscularly to neutralize circulating tetanospasmin that has not yet bound to neural tissue in patients with established tetanus, with a strength of evidence based on multiple guidelines 1, 2
The American Academy of Pediatrics and other guideline societies suggest using separate injection sites if administering TIG concurrently with tetanus toxoid to prevent interference with the immune response 1, 2
Note that TIG cannot reverse damage already caused by toxin that has bound to the central nervous system, highlighting the importance of prompt treatment 3

The World Health Organization recommends performing thorough surgical debridement of all wounds to remove necrotic tissue and create aerobic conditions unfavorable for Clostridium tetani growth in patients with tetanus 4
The Infectious Diseases Society of America suggests initiating antibiotic therapy immediately with metronidazole 500 mg IV every 6-8 hours OR penicillin G 2-4 million units IV every 4-6 hours for 7-14 days to eliminate the organism 3

The Centers for Disease Control and Prevention recommends administering tetanus toxoid vaccine as part of the treatment regimen, since natural infection does not confer immunity, with a strength of evidence based on multiple guidelines 4

The mortality rate for tetanus ranges from 5-50% even with modern intensive care, with higher rates in elderly patients and those with severe disease, according to the Praxis Medical Insights guideline 4
The case-fatality rate remains 18-21% in developed countries with full ICU support, highlighting the importance of prompt and effective treatment 4

The American College of Physicians and other guideline societies advise against delaying TIG administration while awaiting laboratory confirmation—tetanus is a clinical diagnosis, with a strength of evidence based on expert opinion 4
The Centers for Disease Control and Prevention recommends against assuming adequate immunity based on age or history—38% of cases occur in patients ≥65 years, and only 21% of women >70 years have protective antibody levels, highlighting the importance of vaccination 4
The World Health Organization suggests against using equine antitoxin if human TIG is available due to higher risk of allergic reactions and shorter duration of protection, with a strength of evidence based on multiple guidelines 2, 5

The Infectious Diseases Society of America recommends penicillin G 2-4 million units IV every 4-6 hours as an alternative to metronidazole for the treatment of severe tetanus 6

Metronidazole 500 mg IV every 6-8 hours is preferred over penicillin G due to its GABA antagonist properties, according to the Clinical Infectious Diseases journal 6